HKND - ETF AI Analysis

Top Page

Humankind US Stock ETF (HKND)

Rating:69Neutral

Price Target:―

The Humankind US Stock ETF (HKND) has a solid overall rating, driven by strong contributions from holdings like Microsoft and Alphabet. Microsoft benefits from robust revenue growth and strategic investments in cloud and AI, while Alphabet's focus on AI and cloud services enhances its growth potential despite some risks from high valuation. However, weaker holdings such as Intel, which faces profitability and cash flow challenges, may have slightly held back the fund's rating. A key risk factor for the ETF is its exposure to high-valuation stocks, which could impact performance in volatile markets.

Positive Factors

Strong Top Holdings

Several top positions, such as Alphabet and Intel, have delivered strong year-to-date performance, supporting the ETF's overall returns.

Low Expense Ratio

The ETF charges a very low expense ratio, making it cost-effective compared to many other funds.

Sector Diversification

The ETF is spread across multiple sectors, with significant exposure to Health Care, Consumer Defensive, and Technology, reducing reliance on any single industry.

Negative Factors

Over-Concentration in U.S. Market

With nearly all assets focused on U.S. companies, the ETF lacks meaningful global diversification.

Underperforming Holdings

Some holdings, like Procter & Gamble, have shown weak year-to-date performance, which could drag on overall returns.

Heavy Reliance on Health Care Sector

The ETF's large allocation to Health Care (over 40%) increases vulnerability to sector-specific risks.

HKND vs. SPDR S&P 500 ETF (SPY)

AUM141.56M

RegionNorth America

Expense Ratio0.11%

Beta0.66

IssuerHumankind

Inception DateFeb 24, 2021

Dividend Yield1.67%

Asset ClassEquity

Index TrackedHumankind US Equity Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume8,057

30 Day Avg. Volume2,154

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

HKND Summary

The Humankind US Stock ETF (HKND) is a fund that invests in a wide range of U.S. companies while focusing on socially responsible practices. It includes well-known companies like Apple and Microsoft, and covers sectors such as healthcare, technology, and consumer goods. This ETF is ideal for investors who want broad exposure to the U.S. stock market while supporting businesses that positively impact society. However, new investors should be aware that the ETF’s performance can fluctuate with the overall market, as it is tied to the U.S. equity index.

How much will it cost me?The Humankind US Stock ETF (HKND) has an expense ratio of 0.11%, meaning you’ll pay $1.10 per year for every $1,000 invested. This is lower than average because it’s passively managed, focusing on tracking a broad index rather than actively picking stocks.

What would affect this ETF?The Humankind US Stock ETF (HKND) could benefit from growth in the U.S. healthcare and technology sectors, which make up significant portions of its portfolio, especially if innovation and demand in these industries continue to rise. However, the ETF may face challenges if economic conditions worsen, such as higher interest rates or inflation, which could negatively impact consumer spending and corporate earnings across its diverse holdings. Additionally, changes in regulations or public sentiment around socially responsible investing could influence the fund's performance.

HKND Top 10 Holdings

The Humankind US Stock ETF leans heavily into health care, with Eli Lilly and Johnson & Johnson providing steady growth thanks to strong product pipelines and market share gains. Technology also plays a key role, with Alphabet rising on AI and cloud momentum, while Apple shows mixed performance as it navigates supply chain hurdles. On the downside, Archer Daniels Midland and Procter & Gamble are lagging, weighed down by declining margins and cautious outlooks. With a clear focus on U.S. equities and a socially responsible ethos, the fund balances innovation with stability.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
GOOGL	Alphabet Class A	5.51%	$9.19M	$3.62T	78.74%	80 Outperform
LLY	Eli Lilly & Co	3.15%	$5.26M	$1.00T	40.36%	76 Outperform
ADM	Archer Daniels Midland	3.06%	$5.11M	$28.18B	10.60%	63 Neutral
AAPL	Apple	2.75%	$4.59M	$4.01T	16.58%	80 Outperform
JNJ	Johnson & Johnson	2.40%	$4.00M	$491.26B	30.89%	78 Outperform
ABBV	AbbVie	2.38%	$3.97M	$417.60B	33.53%	62 Neutral
BG	Bunge Global	2.35%	$3.92M	$18.29B	6.94%	74 Outperform
INTC	Intel	2.14%	$3.57M	$164.56B	38.72%	56 Neutral
MSFT	Microsoft	1.91%	$3.19M	$3.51T	12.73%	73 Outperform
PG	Procter & Gamble	1.59%	$2.65M	$352.66B	-14.92%	74 Outperform

HKND Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

35.02

Positive

100DMA

34.18

Positive

200DMA

32.69

Positive

Market Momentum

MACD

0.11

Positive

RSI

55.64

Neutral

STOCH

74.50

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HKND, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.24, equal to the 50-day MA of 35.02, and equal to the 200-day MA of 32.69, indicating a bullish trend. The MACD of 0.11 indicates Positive momentum. The RSI at 55.64 is Neutral, neither overbought nor oversold. The STOCH value of 74.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HKND.

HKND Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
HKND	―	―	$141.56M	0.11%	―
FNDB	―	―	$1.04B	0.25%	―
SUSL	―	―	$1.02B	0.10%	―
SYLD	―	―	$869.94M	0.59%	―
PLDR	―	―	$858.73M	0.60%	―
ABFL	―	―	$793.47M	0.49%	―

Performance Comparison

HKND

Humankind US Stock ETF

35.36

2.79

8.57%

FNDB

Schwab Fundamental US Broad Market Index ETF

―

SUSL

iShares ESG MSCI USA Leaders ETF

―

SYLD

Cambria Shareholder Yield ETF

―

PLDR

Putnam Sustainable Leaders ETF

―

ABFL

Fcf Us Quality Etf

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents